Why won’t John Danforth say EMBRYONIC stem cell research?

Question by senior citizen: Why won’t John Danforth say EMBRYONIC stem cell research?
Isn’t this Episcopal minister and former U.S. Senator, who calls them “early stage stem cells” just another liar who won’t face the facts about destroying human life at conception? The private lab that almost fully funded the push for an amendment to Missouri’s Constitution for this purpose now realizes how many Missourians oppose taxation for this doubtful research on moral grounds and is going out of state for more money.
Those who accuse me of being a “bible thumper” fail to realize or admit that Episcopal minister John Danforth, widely thought of by his lawyer colleagues as a “nice man but not very bright”, aligned himself with the interests of one private laboratory and has supported embryonic stem cell research, which is opposed by the Catholic and Lutheran churches (and others) as being immoral. His use of the phrase “early stage stem cell research” is just an attempt to avoid or “negotiate” the question of morality.

Best answer:

Answer by Country Boy
Why won’t anyone just say, “death of fetuses”?

Add your own answer in the comments!

First patient to get stem cell therapy identified

First patient to get stem cell therapy identified
The partially paralyzed young man who was the first person treated in the only carefully designed study of a therapy made from human embryonic stem cells is in good spirits and hopeful about recovering, family and friends said in the first public acknowledgment of his identity and condition.
Read more on Pittsburgh Post-Gazette

Human embryonic stem cells provide new insight into muscular dystrophy
Myotonic dystrophy type 1 is the most common inherited muscular dystrophy in adults. New research uses human embryonic stem cells to make a clinically important contribution to the understanding of this disease, and highlights the incredible potential that embryonic stem cells hold for unraveling the complex molecular mechanisms involved in a variety of human conditions.
Read more on Science Daily

Human Embryonic Stem Cells Provide New Insight Into Muscular Dystrophy
Myotonic dystrophy type 1 (DM1) is the most common inherited muscular dystrophy in adults. New research published by Cell Press online on March 31st in the journal Cell Stem Cell, uses human embryonic stem cells to make a clinically-important contribution to the understanding of this disease, and highlights the incredible potential that embryonic stem cells hold for unraveling the complex …
Read more on redOrbit

The Human Embryonic Stem Cell Debate: Science, Ethics, and Public Policy (Basic Bioethics)

The Human Embryonic Stem Cell Debate: Science, Ethics, and Public Policy (Basic Bioethics)

Human embryonic stem cells can divide indefinitely and have the potential to develop into many types of tissue. Research on these cells is essential to one of the most intriguing medical frontiers, regenerative medicine. It also raises a host of difficult ethical issues and has sparked great public interest and controversy. This book offers a foundation for thinking about the many issues involved in human embryonic stem cell research. It considers questions about the nature of human life, t

Rating: (out of reviews)

List Price: $ 27.00

Price: $ 4.39

What is a Human Embryonic Stem Cell?

Dr. Ann Kiessling of the Bedford Stem Cell Research Foundation narrates a one-minute video about Human Embryonic Stem Cells. These stem cells have the capacity to become any cell in the body. This means they have multiple potential, the term for that is: pluripotent. Bedford Stem Cell Research Foundation

Fintan Walton talks to Gary Rabin, Chairman & CEO of ACT about Human Embryonic Stem Cell Trials.
Video Rating: 5 / 5

Lastest “human Embryonic Stem Cells ” News

EU Partners Advance Multicore and Networking Tech
The EUREKA ITEA 2 software Cluster ParMA project , a software development effort supported by a technology development initiative comprised of European Union members, has announced the completion of several technology development projects that aim to exploit multicore processor architectures to deliver substantial performance improvements for high-performance computing.
Read more on GenomeWeb News

Please Participate in Our Annual Survey of Next-Gen Sequencing Users
‘Tis the season to be surveyed! Please take a moment to respond to a few questions for In Sequence ‘s fourth annual survey of users of next-generation sequencing platforms.
Read more on GenomeWeb News

Future Growth Projection For Human Embryonic Stem Cells (Hescs) Market

Future Growth Projection For Human Embryonic Stem Cells (Hescs) Market

Opportunities in Human Embryonic Stem Cells hESCs Report ( http://www.bharatbook.com/Market-Research-Reports/Opportunities-in-Human-Embryonic-Stem-Cells-hESCs.html ) gives the information about types of stem cell.
 
 Human embryonic stem cells (hESCs) are stem cells derived from the inner cell mass of a blastocyst, which is a stage reach 4-5 days post fertilization. hESCs are the most pluripotent of all stem cell types and can develop into over 200 different cell types of the human body.
 
 hESCs were first derived from mouse embryos in 1981 by Martin Evans and Matthew Kaufman, and independently by Gail R. Martin. In 1995, the first successful culturing of embryonic stem cells from non-human primates occurred at the University of Wisconsin-Madison. Another breakthrough followed at the University of Wisconsin-Madison in November 1998 when a group led by Dr. James Thomson developed a technique to isolate and grow hESCs derived from human blastocysts. Federal funds to support hESC research became available on August 9, 2001, when President Bush announced his decision regarding federal funding for hESC research.
 
 Because of their plasticity and unlimited capacity for self-renewal, hESCs have been proposed for use in wide range of applications, including toxicology testing, tissue engineering, cellular therapies, and basic stem cell biology research. Of particular interest to the medical community is the potential for use of hESCs to heal tissues with naturally limited capacity for renewal, such as the human heart, liver and brain.
 
 This market report recognizes that a wide range of products and services are needed to support this active and well-funded research community. Thus, this report provides:
 
 * Discussion of key advances in hESC research
 * A breakdown of hESC research applications, including shared priorities and priorities by segment
 * hESC patent analysis
 * Historical and future growth projections for the hESC market
 * Competitive analysis of providers of hESC research tools
 * Overview of specialty pharma companies developing hESC therapies
 * Overview of toxicology testing legislation impacting use of hESC in toxicology applications
 * A breakdown of hESC research product categories
 * Suggestions for novel NSC research products, including cells, kits, assays, media and reagents
 * Guidance for companies that wish to offer hESCs products
 * And more… 

 
 Contact us at:
 
 Bharat Book Bureau
 Tel: 91 22 27578668
 Fax: 91 22 27579131
 Email: info@bharatbook.com
 Website: www.bharatbook.com

Bharatbook, the leading information aggregator. We facilitate and support the business information needs. With over 90,000 reports, you can get instant access and insights on the studies in you for market research, corporate / strategic planning by providing the latest information in the form of reports, journals, magazines and databases on varied industries like automotive, oil and gas, shipping, textiles, pharmaceuticals, energy, banking, finance, insurance, risk management, country intelligence, consumer & durable goods, chemical and more your areas of interest. Contact us at +91 22 27578668 / 27579438 or email info@bharatbook.com or our website www.bharatbook.com

Lou Gehrig’s Disease (ALS): Making Astrocytes from Human Embryonic Stem Cells

(Part 4 of 8) Mark Bonyhadi, Ph.D. spoke at the “Spotlight on Disease Team Awards: ALS,” an educational event presented at the CIRM Governing Board meeting on June 23, 2010. Bonyhadi is director of clinical business development for cell therapy in the Cell Therapy Systems group at Invitrogen, part of Life Technologies. To view the other videos in this playlists, go to: www.youtube.com

For the first time, doctors are using human embryonic stem cells to treat a patient with a spinal injury.
Video Rating: 5 / 5

Human Embryonic Stem Cells, Second Edition

Human Embryonic Stem Cells, Second Edition

The Second Edition Of Kiessling And Anderson’s Text, Human Embryonic Stem Cells, Continues To Address The Social, Legal, And Ethical Debates Resulting From The Bush Administration’s Restriction Of Federal Funding For Embryonic Stem Cell Therapy. The Emerging Field Of Human Embryonic Stem Cell Biomedicine Crosses Many Disciplinary Boundaries — Cell Biology, Reproductive Biology, Embryology, Molecular Biology, Endocrinology, Immunology, Fetal Medicine, Transplantation Medicine, And Surgery. Thi

Rating: (out of reviews)

List Price: $ 104.95

Price: $ 19.99

Human Embryonic Stem Cell Protocols (Methods in Molecular Biology)

A comprehensive collection of diverse techniques for the molecular and cellular manipulation of human embryonic stem (hES) cells. These readily reproducible methods have been optimized for the derivation, characterization, and differentiation of hES cells, with special attention given to regenerative medicine applications. A companion CD provides color versions of all illustrations in the book. The protocols follow the successful Methods in Molecular Biology™ series format, each offering step-

Rating: (out of reviews)

List Price: $ 149.00

Price:

Find More “human Embryonic Stem Cells” Products

Powered by WordPress Lab